Bert K. Lopansri,
MD
No Rating Available?
0
out of
5
Patient Rating
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the
minimum.
Languages Spoken: English, Thai
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Infectious Diseases |
| Board Certification | American Board of Internal Medicine (Sub: Infectious Disease) American Board of Medical Microbiology |
Academic Locations
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Infectious Diseases |
| Board Certification | American Board of Internal Medicine (Sub: Infectious Disease) American Board of Medical Microbiology |
Education History
| Other Training | University of Utah School of Medicine Clinical Investigation , 2004 |
| Fellowship | University of Utah School of Medicine Infectious Disease Fellow, 2003 |
| Residency | Loyola University Medical Center Internal Medicine Resident, 2000 |
| Internship | Loyola University Medical Center Internal Medicine Intern, 1998 |
| Professional Medical | Loyola University of Chicago Medicine M.D., 1997 |
| Undergraduate | University of Illinois at Urbana - Champaign Biology B.S., 1993 |
Selected Publications - Journal Articles
Journal Article
- Peltan ID, Beesley SJ, Webb BJ, Lopansri BK, Sinclair W, Jacobs JR, Brown SM (2021). Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing. PLoS One, 16(5), e0251214.
- Riedel S, Halls J, Dutta S, Toraskar N, Lemon J, Carter K, Sinclair W, Lopansri BK, Styer AM, Wolk DM, Walker GT (2021). Clinical evaluation of the acuitas® AMR gene panel for rapid detection of bacteria and genotypic antibiotic resistance determinants. Diagn Microbiol Infect Dis, 100(4), 115383.
- Rubach MP, Mukemba JP, Florence SM, Lopansri BK, Hyland K, Simmons RA, Langelier C, Nakielny S, DeRisi JL, Yeo TW, Anstey NM, Weinberg JB, Mwaikambo ED, Granger DL (2021). Cerebrospinal fluid pterins, pterin-dependent neurotransmitters, and mortality in pediatric cerebral malaria. J Infect Dis.
- Ford CD, Lopansri BK, Coombs J, Webb BJ, Asch J, Hoda D (2020). Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients? Transpl Infect Dis, 22(4), e13279.
- Ford CD, Lopansri BK, Coombs J, Webb BJ, Nguyen A, Asch J, Hoda D (2019). Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes. Clin Transplant, 33(11), e13712.
- Ford CD, Lopansri BK, Webb BJ, Coombs J, Gouw L, Asch J, Hoda D (2018). Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: Incidence, risk factors, and patient outcomes. Am J Infect Control, 47(4), 394-399.
- Walker GT, Quan J, Higgins SG, Toraskar N, Chang W, Saeed A, Sapiro V, Pitzer K, Whitfield N, Lopansri BK, Motyl M, Sahm D (2019). Predicting Antibiotic Resistance in Gram-Negative Bacilli from Resistance Genes. Antimicrob Agents Chemother, 63(4).
- Rubach MP, Zhang H, Florence SM, Mukemba JP, Kalingonji AR, Anstey NM, Yeo TW, Lopansri BK, Thompson JW, Mwaikambo ED, Young S, Millington DS, Weinberg JB, Granger DL (2019). Kinetic and Cross-Sectional Studies on the Genesis of Hypoargininemia in Severe Pediatric Plasmodium falciparum Malaria. Infect Immun, 87(4).
- Lopansri BK, Miller Iii RR, Burke JP, Levy M, Opal S, Rothman RE, DAlessio FR, Sidhaye VK, Balk R, Greenberg JA, Yoder M, Patel GP, Gilbert E, Afshar M, Parada JP, Martin GS, Esper AM, Kempker JA, Narasimhan M, Tsegaye A, Hahn S, Mayo P, McHugh L, Rapisarda A, Sampson D, Brandon RA, Seldon TA, Yager TD, Brandon RB (2019). Physician agreement on the diagnosis of sepsis in the intensive care unit: estimation of concordance and analysis of underlying factors in a multicenter cohort. J Intensive Care, 7, 13.
- Webb BJ, Brunner A, Lewis J, Ford CD, Lopansri BK (2018). Repurposing an Old Drug for a New Epidemic: Ursodeoxycholic Acid to Prevent Recurrent Clostridioides difficile Infection. Clin Infect Dis, 68(3), 498-500.
- Lopansri BK, Anstey NM, Stoddard GJ, Mwaikambo ED, Boutlis CS, Tjitra E, Maniboey H, Hobbs MR, Levesque MC, Weinberg JB, Granger DL (2006). Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications. Infect Immun, 74(6), 3355-9.